E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/21/2019 in the Prospect News Convertibles Daily.

Chegg convertible offering looks cheap, outstanding notes active; GOL Linhas on tap

By Abigail W. Adams

Portland, Me., March 21 – While new deal activity has been light compared to recent weeks, the convertibles primary market will price new paper before the week comes to a close.

Two deals totaling $800 million are slated to price after the market close on Thursday.

Chegg Inc. plans to price $500 million of six-year convertible notes, and GOL Linhas Aereas Inteligentes SA plans to price its offering of $300 million of five-year exchangeable notes.

Both deals look cheap, sources said.

While Chegg’s new offering was in the works, its outstanding 0.25% convertible notes due 2023 were active with holders most likely switching to the new paper, sources said.

Outside of the new paper, Fortive Corp.’s 0.875% convertible notes due 2022 saw high volume activity although with little movement in price.

Ionis Pharmaceuticals Inc.’s 1% convertible notes due 2021 continued to improve with stock breaking out to a new 52-week high over the past week.

Chegg’s new offering

Chegg plans to price $500 million of six-year convertible notes after the market close on Thursday with price talk for a coupon of 0.125% to 0.625% and an initial conversion premium of 27.5% to 32.5%.

Underwriters are marketing the deal with a credit spread of 275 basis points over Libor and a 40% vol., according to a market source.

Based on those assumptions, the deal models about 2.38 points cheap, a source said.

Using a more conservative vol. of 38%, the deal modeled about 1.3 points cheap, another source said.

The company has good cash flow and a decent EBITDA, a market source said.

The deal is coming as a “happy meal” in which approximately $50 million of the proceeds will be used to purchase common stock.

It appears reasonably priced and is expected to do well, a market source said.

Chegg active

Chegg is a repeat issuer of convertible notes with its debut convertible notes offering pricing in March of 2018.

Chegg priced a $300 million issue of five-year convertible notes with a coupon of 0.25% and an initial conversion premium of 32.5% with the greenshoe lifting the total size of the deal to $345 million.

The 0.25% convertible notes have performed well since pricing with the notes already in-the-money.

The 0.25% notes due 2023 were among the most actively traded issues in the secondary space on Thursday.

The notes were changing hands around 158.71 early in the session, a market source said. They dropped alongside stock to 156 later in the afternoon.

Chegg stock closed Thursday at $39.66, a decrease of 3.10%.

More than $5 million of the bonds were on the tape early in the session and more than $23 million traded hands by the late afternoon.

Holders were most likely switching out of the old notes to take positions in the new offering, a market source said.

With Chegg’s 0.25% convertible notes essentially moving alongside equity, some holders, particularly outright accounts, may want more of a bond base, the source said.

GOL Linhas tightens pricing

After an extensive roadshow, GOL Linhas plans to price its offering of $300 million five-year exchangeable notes after the market close on Thursday.

The deal was heard to be doing well during bookbuilding with price talk tightening on Thursday.

Talk tightened to a coupon of 3.75% to 3.875% and an initial exchange premium of 35%, according to a market source.

Price talk was initially for a coupon of 3.75% to 4.25% and an initial exchange premium of 30% to 40%.

The revised pricing was not as beneficial as the original price talk, a market source said. However, the deal must have been in demand.

Timing on the Rule 144A and Regulation S deal was accelerated with the roadshow initially scheduled to run through March 25 with pricing to take place after the market close.

The deal was marketed with a credit spread of 575 bps over Libor and a 40% vol., which modeled about 8 points cheap at the midpoint of initial price talk, according to a market source.

Other sources pegged assumptions as 550 bps over Libor and a 30% vol., which brought the deal to fair value to slightly cheap.

However, the borrow on the Sao Paulo-based airline services operator is difficult. The deal is pricing concurrently with a borrow facility.

Fortive active

Fortive’s 0.875% convertible notes due 2022 saw another day of high-volume activity in the secondary space.

The investment grade paper continued to be in demand, sources said.

The 0.875% convertible notes were changing hands around 104.75. More than $25 million of the bonds were on the tape by the late afternoon.

Fortive stock closed Thursday at $84.22, an increase of 1.48%.

Ionis’ new high

Ionis Pharmaceuticals’ 1% convertible notes due 2021 continued to post gains on Thursday with its stock breaking out to a new 52-week high over the past week.

The 1% convertibles were 133.75 bid, 134.5 offered on Thursday. The notes were improving as stock gains continued, a market source said. Stock has closed above the $80 mark over the past three days.

Ionis hit a new 52-week high of $81.03 in intraday trading on Wednesday.

Stock closed Thursday at $80.50, an increase of 0.36%.

Ionis stock has seen upward momentum since late February when it reported fourth-quarter earnings.

Mentioned in this article:

Chegg Inc. NYSE: CHGG

Fortive Corp. NYSE: FTV

GOL Linhas Aereas Inteligentes SA NYSE: GOL

Ionis Pharmaceuticals Inc. Nasdaq: IONS


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.